Affiliation:
1. Department of Internal Medicine, Atatürk University, Faculty of Medicine, Erzurum, Turkey
2. Department of Gastroenterology, Atatürk University, Faculty of Medicine, Erzurum, Turkey
3. Department of Public Health, Atatürk University, Faculty of Medicine, Erzurum, Turkey
Abstract
Objectives: The incidence of tuberculous peritonitis has been reported between 0.1% and 0.7% among all tuberculosis types. This study, it was aimed to evaluate the cases with tuberculous peritonitis, which has an important place in the differential diagnosis of patients with ascites, clinically, biochemically, microbiologically, and histopathologically.
Methods: : Forty-nine patients with a definite clinical, radiological, and histopathological diagnosis of tuberculous peritonitis, which formed the basis of our study, were analyzed retrospectively.
Results: The mean age of patients with tuberculous peritonitis was found to be 39.45 ± 19.02 years. Purified-protein derivative (PPD) was positive in 23 (72%) of 32 patients with tuberculous peritonitis whose PPD results were recorded, in 9 (28%) PPD results were evaluated as anergic or negative. QuantiFERON-TB Gold In-Tube (QFT-GIT) test was sent in 10 of the patients, the result was positive in 9 (90%) patients and negative in 1 (10%) patient. There were 32 patients in whom tuberculosis polymerase chain reaction (PCR) was studied from ascitic fluid, 7 (22%) of the patients were PCR positive and 25 (78%) negative. Mycobacterium tuberculosis culture positivity was found in 18 (69%) of 26 patients who were biopsied. In total, 29 (59%) of the patients had M. tuberculosis culture positivity.
Conclusions: Tuberculous peritonitis constitutes a public health problem in endemic regions of the world and tuberculous peritonitis should be considered in patients presenting with ascites. Despite all diagnostic difficulties, necessary tests, especially peritoneal biopsy, should be performed for early diagnosis, and it should not be forgotten that early initiation of treatment is very important in terms of morbidity and mortality of the disease.
Publisher
The European Research Journal
Reference15 articles.
1. 1. Demir K, Okten A, Kaymakoglu S, et al. Tuberculous peritonitis--Reports of 26 cases, detailing diagnostic and therapeutic problems. Eur J Gastroenterol Hepatol. 2001;13(5):581-585. doi: 10.1097/00042737-200105000-00019
2. 2. Kushima H, Sakamoto R, Kinoshita Y, et al. Tuberculous peritonitis. BMJ Case Rep. 2021;14(10):e245311. doi: 10.1136/bcr-2021-245311.
3. 3. Al-Knawy BA. Etiology of ascites and the diagnostic value of serum-ascites albumin gradient in non-alcohol liver disease. Ann Saudi Med. 1997;17(1):26-28. doi: 10.5144/0256-4947.1997.26.
4. 4. Sanai FM, Bzeizi KI. Systematic review: tuberculous peritonitis–presenting features, diagnostic strategies, and treatment. Aliment Pharmacol Ther. 2005;22(8):685-700. doi: 10.1111/j.1365-2036.2005.02645.x.
5. 5. Pullukçu H, Taşbakan MS, Sipahi OR, Taşbakan MI, Çalık Ş, Yamazhan T. Pooled analysis of extra-pulmonary tuberculosis in Turkey: a review of 2,168 patients. In: 18th European Congress of Clinical Microbiology and Infectious Diseases; Barcelona, Spain; 2008. p. 1563.